오타코이드 및 관련 약 시장 보고서(2026년)

Autacoids and related drugs are biologically active compounds produced by the body that act locally to regulate physiological functions, usually within specific tissues or organs. They play roles in inflammation, smooth muscle contraction, immune responses, and blood flow regulation. Autacoids function by binding to specific receptors on target cells, triggering signaling pathways that affect cellular activity.

The main types of autacoids and related drugs include histamines, prostaglandins, leukotrienes, serotonin, and bradykinin. Histamines are chemicals released during allergic reactions, causing symptoms such as itching, swelling, and increased stomach acid, and are targeted in treatments for allergies and acid-related conditions. These drugs can be administered via oral, injectable, topical, intranasal, or inhalation routes. They are used for various applications, including cardiovascular disorders, inflammatory diseases, respiratory conditions, allergies, and gastrointestinal issues. The primary end users include hospitals, clinics, homecare settings, and pharmacies.

Tariffs have affected the autacoids and related drug market by increasing the cost of imported active pharmaceutical ingredients, chemical intermediates, and formulation excipients used in histamine, prostaglandin, and leukotriene drugs. These impacts have been most pronounced in cardiovascular and inflammatory disease segments, particularly in north america and europe where API sourcing is globally diversified. Asia-pacific manufacturers have faced pricing pressures due to raw material imports. However, tariffs have encouraged domestic production of generic autacoid-based therapies.

The autacoids and related drug market research report is one of a series of new reports from The Business Research Company that provides autacoids and related drug market statistics, including autacoids and related drug industry global market size, regional shares, competitors with a autacoids and related drug market share, detailed autacoids and related drug market segments, market trends and opportunities, and any further data you may need to thrive in the autacoids and related drug industry. This autacoids and related drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autacoids and related drug market size has grown strongly in recent years. It will grow from $52.81 billion in 2025 to $55.87 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to inflammatory disease prevalence, allergy incidence growth, cardiovascular disorder burden, gastrointestinal disorder treatments, hospital pharmacology expansion.

The autacoids and related drug market size is expected to see strong growth in the next few years. It will grow to $70.07 billion in 2030 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to precision pharmacology adoption, receptor-targeted drug development, chronic disease management growth, outpatient treatment expansion, combination therapy usage. Major trends in the forecast period include expanding use in inflammatory disease management, increased focus on receptor-specific drug action, growing demand for targeted autacoid modulators, rising use in cardiovascular and respiratory care, increased adoption of combination therapies.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the autacoids and related drugs market in the coming years. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including coronary heart disease, heart failure, stroke, and hypertension. This increase is largely linked to poor dietary habits, as excessive intake of saturated fats, trans fats, added sugars, and sodium contributes to high blood pressure, obesity, and elevated cholesterol levels-key risk factors for heart-related conditions. Autacoids and related drugs support cardiovascular health by modulating vascular tone and inflammation, which is critical in conditions such as hypertension and heart failure. Agents targeting pathways involving nitric oxide, endothelin, and prostacyclin help restore endothelial function, promoting vasodilation and lowering vascular resistance. For example, in September 2023, the World Health Organization, a Switzerland-based intergovernmental organization, reported 17.9 million deaths from cardiovascular diseases. Consequently, the growing prevalence of cardiovascular diseases is fueling the expansion of the autacoids and related drugs market.

Leading companies in the autacoids and related drugs market are concentrating on developing innovative products, such as antihistamines, to improve therapeutic effectiveness, minimize side effects, and address emerging allergic and inflammatory conditions with greater precision and safety. Antihistamines are medications that counteract the effects of histamine, a chemical released by the immune system during allergic reactions. For example, in March 2023, Tiefenbacher Pharmaceuticals, a Germany-based pharmaceutical company, launched Bilastine as an over-the-counter (OTC) medicine in Germany, representing a significant advancement in access to effective allergy treatments. The 20 mg Bilastine tablets provide a non-sedating, second-generation antihistamine option for patients experiencing allergic symptoms such as hay fever and urticaria.

In May 2024, Incyte Corporation, a US-based biopharmaceutical company, acquired Escient Pharmaceuticals Inc. for approximately $750 million. Through this acquisition, Incyte aims to expand its immunology portfolio and accelerate the development of novel treatments for pruritus and other inflammatory disorders by incorporating Escient Pharmaceuticals' innovative pipeline of first-in-class, small-molecule therapeutics targeting Mas-related G protein-coupled receptors (MRGPRs). Escient Pharmaceuticals Inc., based in the US, develops novel therapeutics focused on autacoid-related pathways.

Major companies operating in the autacoids and related drug market are Sanofi S.A., Fresenius SE & Co. KGaA, Dr. Reddy's Laboratories Limited, EUROAPI S.A., Pfizer CentreOne, Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

North America was the largest region in the autacoids and related drug market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autacoids and related drug market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the autacoids and related drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The autacoids and related drug market consists of sales of biogenic amines, polypeptide autacoids, lipid-derived autacoids, and leukotrienes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Autacoids And Related Drug Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses autacoids and related drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autacoids and related drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The autacoids and related drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Histamines; Prostaglandins; Leukotrienes; Serotonin; Bradykinin
• 2) By Administration: Oral; Injectable; Topical; Intranasal; Inhalation
• 3) By Application: Cardiovascular Disorders; Inflammatory Diseases; Respiratory Disorders; Allergies; Gastrointestinal Disorders
• 4) By End User: Hospitals; Clinics; Homecare; Pharmacies
• Subsegments:
• 1) By Histamines: H1 Receptor Antagonists; H2 Receptor Antagonists; H3 Receptor Antagonists; H4 Receptor Antagonists; Histamine Agonists
• 2) By Prostaglandins: Prostaglandin E1 (PGE1) Analogs; Prostaglandin E2 (PGE2) Analogs; Prostaglandin F2a (PGF2a) Analogs; Prostaglandin I2 (PGI2) Analogs; Prostaglandin D2 (PGD2) Analogs
• 3) By Leukotrienes: Leukotriene Receptor Antagonists (LTRAs); 5-Lipoxygenase Inhibitors; Leukotriene Synthesis Inhibitors
• 4) By Serotonin: 5-HT1 Receptor Agonists; 5-HT2 Receptor Antagonists; 5-HT3 Receptor Antagonists; 5-HT4 Receptor Agonists; 5-HT6 And 5-HT7 Modulators
• 5) By Bradykinin: Bradykinin B1 Receptor Antagonists; Bradykinin B2 Receptor Antagonists; Bradykinin Receptor Agonists
• Companies Mentioned: Sanofi S.A.; Fresenius SE & Co. KGaA; Dr. Reddy's Laboratories Limited; EUROAPI S.A.; Pfizer CentreOne; Cayman Chemical Company; Tokyo Chemical Industry Co. Ltd.; Avanti Polar Lipids Inc.; Kyowa Pharma Chemical Co. Ltd.; Nicox S.A.; Glentham Life Sciences Ltd.; LGM Pharma Inc.; chemBlink Inc.; ZellBio GmbH; AquigenBio LLC; BOC Sciences Inc.; Yarrow Chem Products Pvt. Ltd.; LEBSA S.A.; VDK NaturaSyn S.A.; Enzo Life Sciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Autacoids And Related Drug Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Autacoids And Related Drug Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Autacoids And Related Drug Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Autacoids And Related Drug Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Expanding Use In Inflammatory Disease Management
  • 4.2.2 Increased Focus On Receptor-Specific Drug Action
  • 4.2.3 Growing Demand For Targeted Autacoid Modulators
  • 4.2.4 Rising Use In Cardiovascular And Respiratory Care
  • 4.2.5 Increased Adoption Of Combination Therapies

5. Autacoids And Related Drug Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Clinics
• 5.3 Homecare Providers
• 5.4 Specialty Treatment Centers
• 5.5 Pharmacies

6. Autacoids And Related Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Autacoids And Related Drug Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Autacoids And Related Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Autacoids And Related Drug Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Autacoids And Related Drug Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Autacoids And Related Drug Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Autacoids And Related Drug Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Autacoids And Related Drug Market Segmentation

• 9.1. Global Autacoids And Related Drug Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Histamines, Prostaglandins, Leukotrienes, Serotonin, Bradykinin
• 9.2. Global Autacoids And Related Drug Market, Segmentation By Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oral, Injectable, Topical, Intranasal, Inhalation
• 9.3. Global Autacoids And Related Drug Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiovascular Disorders, Inflammatory Diseases, Respiratory Disorders, Allergies, Gastrointestinal Disorders
• 9.4. Global Autacoids And Related Drug Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Clinics, Homecare, Pharmacies
• 9.5. Global Autacoids And Related Drug Market, Sub-Segmentation Of Histamines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• H1 Receptor Antagonists, H2 Receptor Antagonists, H3 Receptor Antagonists, H4 Receptor Antagonists, Histamine Agonists
• 9.6. Global Autacoids And Related Drug Market, Sub-Segmentation Of Prostaglandins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prostaglandin E1 (PGE1) Analogs, Prostaglandin E2 (PGE2) Analogs, Prostaglandin F2a (PGF2a) Analogs, Prostaglandin I2 (PGI2) Analogs, Prostaglandin D2 (PGD2) Analogs
• 9.7. Global Autacoids And Related Drug Market, Sub-Segmentation Of Leukotrienes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Leukotriene Receptor Antagonists (LTRAs), 5-Lipoxygenase Inhibitors, Leukotriene Synthesis Inhibitors
• 9.8. Global Autacoids And Related Drug Market, Sub-Segmentation Of Serotonin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 5-HT1 Receptor Agonists, 5-HT2 Receptor Antagonists, 5-HT3 Receptor Antagonists, 5-HT4 Receptor Agonists, 5-HT6 And 5-HT7 Modulators
• 9.9. Global Autacoids And Related Drug Market, Sub-Segmentation Of Bradykinin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bradykinin B1 Receptor Antagonists, Bradykinin B2 Receptor Antagonists, Bradykinin Receptor Agonists

10. Autacoids And Related Drug Market Regional And Country Analysis

• 10.1. Global Autacoids And Related Drug Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Autacoids And Related Drug Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Autacoids And Related Drug Market

• 11.1. Asia-Pacific Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Autacoids And Related Drug Market

• 12.1. China Autacoids And Related Drug Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Autacoids And Related Drug Market

• 13.1. India Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Autacoids And Related Drug Market

• 14.1. Japan Autacoids And Related Drug Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Autacoids And Related Drug Market

• 15.1. Australia Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Autacoids And Related Drug Market

• 16.1. Indonesia Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Autacoids And Related Drug Market

• 17.1. South Korea Autacoids And Related Drug Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Autacoids And Related Drug Market

• 18.1. Taiwan Autacoids And Related Drug Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Autacoids And Related Drug Market

• 19.1. South East Asia Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Autacoids And Related Drug Market

• 20.1. Western Europe Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Autacoids And Related Drug Market

• 21.1. UK Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Autacoids And Related Drug Market

• 22.1. Germany Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Autacoids And Related Drug Market

• 23.1. France Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Autacoids And Related Drug Market

• 24.1. Italy Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Autacoids And Related Drug Market

• 25.1. Spain Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Autacoids And Related Drug Market

• 26.1. Eastern Europe Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Autacoids And Related Drug Market

• 27.1. Russia Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Autacoids And Related Drug Market

• 28.1. North America Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Autacoids And Related Drug Market

• 29.1. USA Autacoids And Related Drug Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Autacoids And Related Drug Market

• 30.1. Canada Autacoids And Related Drug Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Autacoids And Related Drug Market

• 31.1. South America Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Autacoids And Related Drug Market

• 32.1. Brazil Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Autacoids And Related Drug Market

• 33.1. Middle East Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Autacoids And Related Drug Market

• 34.1. Africa Autacoids And Related Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Autacoids And Related Drug Market, Segmentation By Type, Segmentation By Administration, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Autacoids And Related Drug Market Regulatory and Investment Landscape

36. Autacoids And Related Drug Market Competitive Landscape And Company Profiles

• 36.1. Autacoids And Related Drug Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Autacoids And Related Drug Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Autacoids And Related Drug Market Company Profiles
  • 36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. EUROAPI S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Pfizer CentreOne Overview, Products and Services, Strategy and Financial Analysis

37. Autacoids And Related Drug Market Other Major And Innovative Companies

• Cayman Chemical Company, Tokyo Chemical Industry Co. Ltd., Avanti Polar Lipids Inc., Kyowa Pharma Chemical Co. Ltd., Nicox S.A., Glentham Life Sciences Ltd., LGM Pharma Inc., chemBlink Inc., ZellBio GmbH, AquigenBio LLC, BOC Sciences Inc., Yarrow Chem Products Pvt. Ltd., LEBSA S.A., VDK NaturaSyn S.A., Enzo Life Sciences Inc.

38. Global Autacoids And Related Drug Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Autacoids And Related Drug Market

40. Autacoids And Related Drug Market High Potential Countries, Segments and Strategies

• 40.1 Autacoids And Related Drug Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Autacoids And Related Drug Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Autacoids And Related Drug Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer